COVID-19 in an adolescent with aplastic anemia undergoing immunosuppressive therapy: A case report and details of antibody testing for SARS-CoV-2

Pediatr Blood Cancer. 2022 Feb;69(2):e29332. doi: 10.1002/pbc.29332. Epub 2021 Sep 5.

Authors

Shota Kato¹, Yoshiko Nakano^{1

2}, Yuki Nakano³, Koh Okamoto⁴, Nao Takasugi¹, Moe Hidaka¹, Masahiro Sekiguchi¹, Mitsuteru Hiwatari^{1

2}, Makoto Kurano³, Motohiro Kato¹

Affiliations

¹ Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
² Department of Cell Therapy and Transplantation Medicine, The University of Tokyo Hospital, Tokyo, Japan.
³ Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo, Japan.
⁴ Department of Infectious Diseases, The University of Tokyo, Tokyo, Japan.

No abstract available

Publication types

Letter
Comment

MeSH terms

Adolescent
Anemia, Aplastic* / diagnosis
Anemia, Aplastic* / drug therapy
COVID-19*
Humans
Immunosuppression Therapy
SARS-CoV-2